Nanuet, NY, United States of America

Kiran Khandke

USPTO Granted Patents = 7 

 

 

Average Co-Inventor Count = 6.6

ph-index = 4

Forward Citations = 117(Granted Patents)


Company Filing History:


Years Active: 2011-2018

Loading Chart...
Loading Chart...
Loading Chart...
7 patents (USPTO):Explore Patents

Title: The Innovative Journey of Inventor Kiran Khandke

Introduction

Kiran Khandke, an accomplished inventor based in Nanuet, NY, has made significant contributions to the field of biotechnology, particularly in the development of innovative antibody-drug conjugates. With a remarkable portfolio of seven patents, Khandke's work continues to impact medical science and therapeutic approaches.

Latest Patents

Among Khandke's latest innovations are notable patents that focus on advanced antibody technologies. His invention of Anti-5T4 antibodies underscores the potential for cancer treatment, providing methods for the use of anti-5T4 antibody/drug conjugates. Additionally, he developed anti-EFNA4 antibody-drug conjugates, which include innovative methods for preparing and utilizing these conjugates in various medical applications.

Career Highlights

Kiran Khandke has built a robust career in the pharmaceutical industry, working with prestigious companies such as Wyeth and Pfizer Corporation. His expertise in antibody development and therapeutic applications has established him as a figure of excellence in his field, garnering respect from peers and colleagues.

Collaborations

Throughout his career, Khandke has collaborated with talented individuals, including Kimberly Ann Marquette and Lioudmila Tchistiakova. These partnerships have fostered a creative environment that has led to groundbreaking advancements in pharmaceutical therapies.

Conclusion

Kiran Khandke's innovative contributions to the field of biotechnology through his patents and collaborations represent a significant advancement in medical treatments. His ongoing work continues to inspire future innovations that aim to improve patient outcomes and enhance therapeutic options.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…